Sarepta Therapeutics (SRPT) Receivables - Net (2010 - 2026)
Sarepta Therapeutics' Receivables - Net was $376.82 million in Q2 2026, down 28.5% from $527.3 million a year earlier and down 4.6% from the prior quarter.
Sarepta Therapeutics (SRPT) Receivables - Net (2010 - 2026) Analysis & Trends
At the end of FY2025, Receivables - Net at Sarepta Therapeutics came in at $398.23 million, down 33.8% from FY2024.
- Receivables - Net shows a five-year compound annual growth rate of 31.5% (FY2020 to FY2025).
- In earlier years, Receivables - Net was $601.99 million in FY2024 (+50.4%), $400.33 million in FY2023 (+86.5%), $214.63 million in FY2022 (+40.3%) and $152.99 million in FY2021 (+51.0%).
- The Q2 2026 figure marks the lowest quarterly Receivables - Net since Q2 2024.
- Compared with a year earlier, Receivables - Net has declined for four straight quarters, with growth averaging 12.0% over the last eight quarters.
- The best year-over-year quarter for Receivables - Net over five years was Q4 2023 (growth of 86.5%); the worst was Q1 2026 (a decline of 40.1%).
- Per Business Quant data, SRPT's Receivables - Net in the three quarters before Q2 2026 was $394.82 million (Q1 2026), $398.23 million (Q4 2025) and $395.74 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Sarepta Therapeutics | 1.99 Bn | -1.25 Bn | 251.87 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 376.82 Mn |
| Mar 31, 2026 | 394.82 Mn |
| Dec 31, 2025 | 398.23 Mn |
| Sep 30, 2025 | 395.74 Mn |
| Jun 30, 2025 | 527.30 Mn |
| Mar 31, 2025 | 659.37 Mn |
| Dec 31, 2024 | 601.99 Mn |
| Sep 30, 2024 | 434.52 Mn |
| Jun 30, 2024 | 360.00 Mn |
| Mar 31, 2024 | 378.81 Mn |
| Dec 31, 2023 | 400.33 Mn |
| Sep 30, 2023 | 318.86 Mn |
| Jun 30, 2023 | 236.81 Mn |
| Mar 31, 2023 | 223.84 Mn |
| Dec 31, 2022 | 214.63 Mn |
| Sep 30, 2022 | 201.51 Mn |
| Jun 30, 2022 | 203.85 Mn |
| Mar 31, 2022 | 178.19 Mn |
| Dec 31, 2021 | 152.99 Mn |
| Sep 30, 2021 | 149.79 Mn |
Sarepta Therapeutics Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=SRPT&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "SRPT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=SRPT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();